Health Care Weekly: InnovAge Settles Probes of Business Practices Sparked by Capitol Forum Report; CMS Finalizes Phosphate Binder Rate; House Panel Asks CBO to Revisit No Surprises Act; CVS Bumps Dexcom from Formularies; Health Plan Marketers Face FTC Scrutiny; FDA Floats Approval Pathway for Gene Editing; Medicaid Work Requirements Rule Unlawful, Court Says

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. In this edition: • InnovAge settles False Claims Act probes with DOJ and states • Final dialysis payment rule features lower phosphate binder boost than proposed • E&C Committee asks CBO to […]

Published on Nov 04, 2026

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

Copyright ©2026 The Capitol Forum. All Rights Reserved.